Spark Therapeutics to Participate in J.P. Morgan Healthcare Conference
PHILADELPHIA, Jan. 03, 2017 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, announced today that Jeffrey D. Marrazzo, chief executive officer, is …